Study to find better drug among injection methotrexate and injection triamcinolone acetonide in patients of psoriasis
Phase 4
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2024/04/066155
- Lead Sponsor
- Sampath V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)All patients with clinical features of chronic Plaque psoriasis with less than 5 Plaques
2)Patients who have given consent for the study and are willing to come for regular follow up at the psoriasis clinic.
3)Patients who had not been on any systemic and topical anti psoriatic medications for at least the past 2 months will be enrolled.
Exclusion Criteria
1)Patients with unstable psoriasis
2)Pregnant and Lactating Women
3)Patients of Psoriasis vulgaris with history of Hypersensitivity to MTX or Triamcinolone.
4)Patients with bleeding disorders and on anti-coagulant therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To compare the efficacy of intralesional Methotrexate (MTX) and Triamcinolone in the treatment of Chronic plaque psoriasis both clinically and using Dermoscopy.Timepoint: 6 weeks,12 weeks,24 weeks
- Secondary Outcome Measures
Name Time Method 2.To compare the common side effects of Intralesional Methotrexate and Triamcinolone Acetonide in Chronic Plaques Psoriasis.Timepoint: 6 weeks,12 weeks,24 weeks